Microbiological Testing/Measurement TRIZ Cases

Ligation probes hybridize to target nucleic acid fragments and form ligatable junctions, resolving amplification artefacts in multiplex genomic detection.

Removing inorganic salts from lyophilized nucleic acid kits prevents hygroscopic rehydration and preserves enzyme stability during storage.

Automated instrument assigns compatibility index values to assay protocols for concurrent molecular diagnostic testing.

Real-time polymerase chain reaction targets the esxJ gene to amplify and detect Mycobacterium tuberculosis genetic material in biological samples.

A microfluidic device uses controlled thermal ablation to access interstitial fluid through the stratum corneum for non-invasive biomarker collection.

Two-phase actuation signals position droplets and relax them into gaps, preventing fusion for reliable interface formation.

Marker-assisted stacking of CRL1 and CRL2 genes overcomes linkage drag to deliver durable, broad-spectrum protection against Plasmodiophora brassicae.

A method corrects deamination-induced sequencing errors in cell-free nucleic acids using blunt-ended molecule generation.

Repair compounds neutralize oxidative stress in stressed Legionella pneumophila, reducing detection latency and preventing artifactual death during enumeration.

A cell cage array isolates individual cells for parallel nucleic acid amplification and sequencing.

Dissolving water-soluble beads containing analytes in a liquid matrix creates customizable quality control solutions for clinical diagnostics.

Analyzing ZNF304 and ZNF264 methylation status distinguishes colon cancer from other tissues, resolving specificity issues inherent in broad tumor markers.

Multi-wavelength light source applies orthogonal code signals to PCR chips, reducing noise and photo bleaching during DNA amplification cycle counts.

Replacing radiolabels with tagged probes and LC-MS eliminates radiation hazards while maintaining high-resolution capping efficiency measurement.

Maternal plasma DNA analysis determines fetal zygosity without invasive procedures by measuring genetic differences in maternal circulation.

Lettuce variety 41-49 RZ applies self-service breeding to resist pests and diseases, eliminating pesticide residues while maintaining heart quality.

Rolling circle amplification counts single nucleic acid copies to reduce analysis time and device complexity compared to next generation sequencing.

Fluorescence microscopy imaging detects nucleic acid content and cell stretching to classify microbial populations into viable cultivable, non-cultivable, and dead categories.

Quantitating methylation in multiple genomic targets via pyrosequencing detects prostate cancer field defects, reducing reliance on invasive biopsy sampling.

Engineered antibody degrades c-Met without Cbl dependency, treating diseases in subjects with low Cbl levels or mutations.

Segmented two-stage amplification generates fluorescent amplicons that hybridize to microarray probes, resolving false negatives at low viral loads.

Linker-free segmented barcodes on bead-immobilized Tn5 transposase resolve barcode collision and contiguity loss in standard short-read sequencing.

System analyzes multi-dimensional RT-qPCR arrays to predict toxin levels, resolving the trade-off between monitoring complexity and information loss.

A miRNA biomarker approach enables accurate diagnosis of mild traumatic brain injury using molecular profiles.

Blocking moieties prevent futile turnover during motor protein loading, enhancing nanopore sensing accuracy.

RNA profiling assay detects alternative splice variants and metabolic gene activity to guide personalized treatment strategies against resistance development.

Vacuum aspiration through a glass capillary isolates live cells without fixation or dissociation, preserving RNA integrity.

Analyzing immune defense and T-cell receptor signaling genes to personalize dosing, reducing side effects while maintaining treatment effectiveness.

A structured capture array isolates biomarkers from complex fluids using controlled humidity and capillary forces.

Selective lysis releases non-rare cell nucleic acids to prevent contamination, enabling high purity recovery of intact rare cell RNA.

Mass spectrometry profiles tissue samples to identify specific molecular signatures in melanocytic lesions.

Adhesive patches collect skin samples for non-invasive gene expression analysis, resolving the trade-off between patient comfort and detection sensitivity.

A biosensor uses two capture molecules with distinct dissociation rates to enhance switching activity and signal detection.

Statistical sequence tag frequency analysis calculates single chromosome doses to resolve detection sensitivity limits in non-invasive prenatal testing.

A gene expression analysis system classifies breast cancer samples into molecular subtypes using a specific multi-gene signature.

A Breast Cancer Index assay classifies patients into distinct risk categories using specific mRNA expression levels.

An electrochemical system detects liver enzymes using pyruvate oxidase to generate measurable electrical signals from reaction products.

Saponin treatment disrupts host cell membranes to release nucleic acids into acellular fractions for subsequent enzymatic digestion.

Distinct thermal melting peaks from specific probes resolve overlapping signals to identify heterozygous immune gene variants.

Analyzing LAG3, LGALS9, TDO2, TMIGD2, and VTCN1 expression levels resolves the contradiction between prediction accuracy and treatment side effects.

Combining mucin and CEACAM biomarkers in cyst fluid resolves low diagnostic reliability by enabling precise malignant potential stratification.

Segmented chambers and internal fluid paths separate sterilants from biological sources, ensuring reliable validation without cross-contamination.

Segmented alder leaf agar carriers standardize aquatic fungi biofilm growth, resolving variability in fungicide risk assessment.

A serum fucosidase detection kit uses a stabilized substrate system to maintain reagent integrity for clinical analysis.

Engineered Taq polymerases with modified Klenow fragments enable accurate SNP detection and methylation analysis without prior DNA purification.

A gene signature comprising ITGB4 and SNAI2 discriminates lymph node status in breast cancer patients through expression analysis.

Analyzing urine for TERT promoter mutations resolves poor sensitivity of existing markers by detecting low-grade tumors and monitoring recurrence.

Segmenting culture steps with molecular extraction reduces analysis time from weeks to under 24 hours while maintaining detection reliability.

Salivary microRNAs differentiate exercise states from concussions, resolving protein biomarker sensitivity limits.